ArticleAmerican journal of translational research2025
The application of rotational atherectomy in PCI for patients with complex coronary artery calcified lesions.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the safety and efficacy of rotational atherectomy (RA) in the treatment of complex coronary calcified lesions and to identify factors associated with patient prognosis.
methodsA retrospective study was conducted on 200 patients who underwent RA at Hunan Provincial People's Hospital between January 2022 and March 2024. Baseline demographics, angiographic, procedural, and laboratory variables were collected. Major adverse cardiovascular events (MACE) after discharge were recorded through scheduled clinic visits and telephone follow-up (median, 12 months). All patients received standardized RA, intracoronary imaging guidance, and 12-month dual antiplatelet therapy. Pre- and post-procedural parameters were compared using paired tests, and multivariable logistic regression was performed to identify independent predictors of adverse outcomes.
resultsRA significantly increased the minimum lumen area (2.31 mm
conclusionRA effectively improves luminal dimensions in complex coronary calcified lesions. Concomitant hypertension and DM are independent risk factors for poor prognosis after RA. Among patients with both conditions, advanced age, left main coronary artery lesion, and larger maximum burr diameter may predict worse clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.